The Athena trials: Autologous adipose‐derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction

D. Henry, Timothy; J. Pepine, Carl; R. Lambert, Charles; H. Traverse, Jay; A. Schatz, Richard; Costa, Marco; J. Povsic, Thomas; David Anderson, R.; T. Willerson, James; Kesten, Steven; C. Perin, Emerson

doi:10.1002/ccd.26601

Public

The Athena trials: Autologous adipose‐derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction

Published in Catheterization and Cardiovascular Interventions • May 5, 2016

Authors:

Timothy D. Henry

Carl J. Pepine

Charles R. Lambert

Abstract

OBJECTIVE: To assess safety and feasibility of autologous adipose-derived regenerative cells (ADRCs), for treatment of chronic ischemic cardiomyopathy patients. BACKGROUND: Preclinical and early clinical trials suggest ADRCs have excellent potential for ischemic conditions. METHODS: The Athena progr...

Subject

Medicine

Cardiology

Adipose tissue

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!